Johnson & Johnson Cancer Litigation Overview
Johnson & Johnson faces tens of thousands of lawsuits alleging its talc-based products caused ovarian cancer and mesothelioma. Most claims target baby powder and shower-to-shower products. Plaintiffs argue the company knew about asbestos contamination for decades. J&J has consistently denied the claims and maintains its talc is safe. The litigation has become one of the largest mass tort cases in U.S. history. Many cases are consolidated in federal courts under multidistrict litigation.Read more on Forbes.
The company has recorded billions in reserves for potential talc-related losses. In 2024, J&J reported ongoing charges tied to settlement offers and litigation costs. The legal reserve balance reflects management's estimate of probable losses. Analysts track these charges closely as a key indicator of financial exposure. The U.S. bankruptcy court in North Carolina has been central to the talc docket. J&J created a subsidiary, LTL Management LLC, to handle talc claims through bankruptcy.SEC filing details.
Recent Settlements, Verdicts, and Financial Impact
J&J has settled thousands of talc lawsuits in recent years. Settlement amounts vary widely based on case specifics and jurisdiction. Some individual verdicts have exceeded 2 billion dollars in plaintiff favor. However, many verdicts are later reduced or overturned on appeal. The company uses settlement offers to manage litigation risk and avoid lengthy trials. J&J's legal strategy focuses on challenging the scientific basis of plaintiff claims.Forbes coverage.
The talc litigation has weighed on J&J's market capitalization and credit ratings. Bond investors monitor the company's debt and leverage ratios closely. J&J's consumer health division has faced declining sales amid safety concerns. The company has also faced investor lawsuits over disclosure of talc risks. Institutional shareholders have filed resolutions requesting greater transparency. J&J's board has responded with enhanced risk committee oversight of the talc issue.SEC EDGAR filings.
Scientific Evidence, Regulatory Status, and Company Response
The International Agency for Research on Cancer classifies talc as possibly carcinogenic to humans. IARC based this on evidence linking perineal talc use to ovarian cancer. The U.S. Food and Drug Administration has tested talc products for asbestos contamination. Some FDA lab analyses detected trace asbestos fibers in certain samples. J&J disputes these findings and cites its own extensive testing. The company maintains its talc meets all regulatory safety standards worldwide.FDA talc information.
J&J has invested in consumer education and reformulation of its product lines. The company has phased out talc in many markets and introduced corn